MWX Mineworx Technologies Ltd

A year after announcing a focus on bringing its patient flow solution to market, Medworxx sees strategic affirmation through consistent revenue growth, new branding, client satisfaction and alignment with market drivers - while continuing with a solid business in other solution areas. TORONTO, Oct. 5, 2011 /CNW/ - Medworxx Inc. ("Medworxx") , a leader in clinical patient flow, compliance and education solutions, announced today the achievement of multiple milestones in the 12 months since setting a strategic roadmap focusing on the Canadian and international patient flow markets. Highlights of the Company's year over year progress include: -- Since initiating the patient flow strategy, the Company has built to consistent double digit growth quarter on quarter. -- Medworxx Patient Flow Solutions now serves 25% of Canadian hospital beds, including implementations at the Provincial, Local Health Integration Network (LHIN), regional and local levels. -- A partnership program geared to performance improvement consultants is launching to bring the Medworxx Patient Flow Solution to UK, Australia, US and other international markets. -- Medworxx Compliance and Education Solutions continue to grow, adding 7 new hospital clients in the first half of 2011 and building on a strong base of recurring revenue. Medworxx is exploring options for the platform that include strategic partnerships to increase distribution primarily within the United States, a strategic sale of the assets, expansion outside of the healthcare markets, and divestiture or spin-out of these assets as a standalone business unit. -- New brand launch of Medworxx Patient Flow website, branding and messaging staking claims in market. -- Patient flow clients affirm value in 2011 Client Insight Survey on flagship Medworxx Utilization Management System (UMS) with responses including 96% agreement that data enables strategies to reduce days where patients are ready for discharge but remain in hospital. -- Market drivers continue to gain force with the recognition that improving key patient flow areas lead directly to reduction in inappropriate time spent in hospital. Recent Provincial reports and hospital quality improvement plans directly reference Medworxx clients as success examples. "We announced 12 months ago that we are pointing a lot of our efforts in the patient flow market direction and we're seeing the strategy come to fruition," said Dan Matlow, President and CEO, Medworxx.  "We're on track to building depth in our international presence on this solid foundation of Canadian growth." The company is also reporting the grant 1,021,150 options to certain officers, directors and employees of the company, pursuant to the company's employee stock option plan. They replace 355,373 of options expired in 2011 for a net new allocation of 665,777 options. Each option under the plan is exercisable to acquire one common share at a price of 16 cents per share. The options granted have been approved by the board of directors and are due to expire on September 7, 2016. The plan has been approved by the company's shareholders. For more information on the materials, reports and survey results detailed, visit the Patient Flow area of www.medworxx.com . About Medworxx Medworxx is a Toronto-based software company focused on solutions for the North American and international healthcare marketplaces. Medworxx provides healthcare solutions for patient flow, compliance and education, with software comprising an integrated suite of solutions, including content management, learning management, policies and procedures, utilization management, bed optimization, single sign on, portal, and emergency readiness solutions. Medworxx started business in May 2004 in Ontario with 3 employees and has since grown to over 35 employees. Medworxx' executive team consists of experienced sales, marketing, software development, healthcare, and finance personnel. Medworxx currently has a customer base of approximately 100 healthcare organizations representing almost 300 hospitals a who are distributed approximately 75% in Canada and 25% in the United States, with a growing UK presence. The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release. This press release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors, such as competition, technological changes, the changing needs of hospitals, the financial condition of the Company's current and potential customers, foreign currency exchange rates, as well as general economic conditions, which may cause the actual results, performance or achievements of the Corporation and Medworxx to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this press release. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements Medworxx Inc. CONTACT: Julia Zarb, PhDSVP Marketing & Strategy, Medworxx Inc.Suite 700, 121 Richmond St West, Toronto, Canada M5H 2K1T: 1.800.321.1591 | T:416.642.1278 x322 | M: 416.418.3641Jzarb@medworxx.com | www.Medworxx.com

Copyright